What's New? Q1-23
Bruker Launches de novo Sequencing for Immunopeptidomics,...
Dr. Andrew I Webb explores how advanced proteomics and Targeted Protein Degradation (TPD) are revolutionizing drug discovery, unlocking new...
October 15, 2024
How we learnt to increase executive presence, harness the power of story telling and gain confidence presenting beyond the lab
August 28, 2024
Bruker Launches de novo Sequencing for Immunopeptidomics,...
March 06, 2023
If you are new to the MassGeek Community, welcome! We're so glad...
December 21, 2022
In my opinion, MSP is one of the most exciting areas in biological...
December 20, 2022
It feels so much longer but it's only been a few days since over...
June 20, 2022
Is it just us or is the year flying by? We can't believe it's April...
April 04, 2022
Over the last few years, I had the great fortune to be able to follow...
February 16, 2022
Welcome to the November 2021 edition of the #MassGeek PlayBook. While...
October 31, 2021
Last week, the Mass Dynamics (MD) team published our first peer...
October 20, 2021
Making sense of data one protein at a time is not only unpractical,...
June 23, 2021
It’s been a busy few months at Mass Dynamics' HQ as we on boarded...
April 20, 2021
Over the past 20 years, Mass Spectrometry (MS) and Bioinformatics...
March 22, 2021
*We won’t sell your information or spam you, and you can unsubscribe at any time.